Société Novartis AG Nyse

Société Novartis AG Nyse

NVS

US66987V1098

Produits pharmaceutiques

Consensus des Analystes

Actions

NVS

US66987V1098

Produits pharmaceutiques

Consensus des Analystes

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Novartis AG

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Novartis AG

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Marché Fermé - Nyse Autres places de cotation 22:00:02 26/04/2024			Varia. 5j.	Varia. 1 janv.
97,44 ^USD	-1,64 %		+3,26 %	-3,50 %

26/04	Bourse Zurich: le SMI peu impressionné par le regain d'inflation aux USA	AW
26/04	Bourse Zurich: le SMI se maintient dans le vert avant l'inflation US	AW

Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA (hors activités abandonnées) par domaine thérapeutique se répartit comme suit :

- oncologie (29,9%) ;

- immunologie (17,2%) ;

- maladies cardio-vasculaires, rénales et métaboliques (14,1%) ;

- neuroscience (8,9%) ;

Le solde du CA (29,9%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques.

A fin 2023, Novartis AG dispose de 33 sites de production dans le monde.

La répartition géographique du CA est la suivante : Europe (33%), Etats-Unis (39,5%), Asie-Afrique-Australasie (20,5%), Canada et Amérique latine (7%).

Nombre d'employés: 76 057

CHF en Millions	2022	Poids	2023	Poids	Delta
Established Brands 30,0 %	-	-	12 238	30,0 %	-
Oncology 29,9 %	-	-	12 213	29,9 %	-
Immunology 17,2 %	-	-	7 008	17,2 %	-
Cardiovascular, Renal and Metabolic 14,1 %	-	-	5 743	14,1 %	-
Neuroscience 8,9 %	-	-	3 633	8,9 %	-

CHF en Millions	2022	Poids	2023	Poids	Delta
United States 39,5 %	16 860	34,9 %	16 139	39,5 %	-4,28 %
Europe 18,9 %	10 469	21,7 %	7 704	18,9 %	-26,41 %
Asia/Africa/Australasia 9,1 %	4 975	10,3 %	3 700	9,1 %	-25,63 %
Germany 7,4 %	4 086	8,5 %	3 026	7,4 %	-25,94 %
China 7,2 %	2 987	6,2 %	2 936	7,2 %	-1,73 %
Canada and Latin America 7,0 %	3 709	7,7 %	2 854	7,0 %	-23,04 %
Japan 4,2 %	2 106	4,4 %	1 729	4,2 %	-17,90 %
France 3,8 %	2 156	4,5 %	1 572	3,8 %	-27,09 %
Switzerland 2,9 %	926	1,9 %	1 175	2,9 %	+26,88 %

Dirigeants	Titre	Age	Depuis
Vasant Narasimhan CEO	Chief Executive Officer	48	01/01/05
Harry Werner Kirsch DFI	Director of Finance/CFO	59	01/01/03
Shreeram Aradhye CTO	Chief Tech/Sci/R&D Officer	62	16/05/22
Steffen Lang COO	Chief Operating Officer	57	01/04/17
Klaus Moosmayer CMP	Compliance Officer	56	01/12/18
Samir Shah IRO	Public Communications Contact	63	01/01/04
Simon Brown PRN	Corporate Officer/Principal	-	01/08/13
Kees Roks AUD	Comptroller/Controller/Auditor	61	01/05/22
Linda Kanitra PRN	Corporate Officer/Principal	-	-
Robert Kowalski HRO	Human Resources Officer	56	01/09/21

Administrateurs	Titre	Age	Depuis
Bill Winters BRD	Director/Board Member	62	01/01/13
Simon Moroney BRD	Director/Board Member	65	28/02/20
Hans Jörg Reinhardt CHM	Chairman	68	01/01/13
John Young BRD	Director/Board Member	60	07/03/23
Bridgette Heller BRD	Director/Board Member	62	28/02/20
Ton Büchner BRD	Director/Board Member	59	01/01/16
Charles Sawyers BRD	Director/Board Member	65	01/01/13
Nancy Andrews BRD	Director/Board Member	65	01/01/15
Patrice Bula BRD	Director/Board Member	68	28/02/19
Frans van Houten BRD	Director/Board Member	64	28/02/17

	Vote	Nombre	Flottant	Autocontrôle	Flottant Total
Action A	1	2 189 930 497	1 866 336 959 ( 85,22 %)	233 443 766 ( 10,66 %)	85,22 %

Nom	Actions	%	Valorisation
NOVARTIS AG 6,625 %	145 083 991	6,625 %	14 073 M $
Sandoz Family Foundation 4,070 %	89 135 960	4,070 %	8 646 M $
UBS Asset Management Switzerland AG 3,123 %	68 391 910	3,123 %	6 634 M $
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 0,3011 %	6 593 896	0,3011 %	640 M $
State Street Global Advisors Ltd. 0,2103 %	4 604 889	0,2103 %	447 M $
UBS AG (Investment Management) 0,1782 %	3 902 170	0,1782 %	379 M $
La Mondiale SAM (Investment Portfolio) 0,1776 %	3 888 630	0,1776 %	377 M $
MFS International (UK) Ltd. 0,1769 %	3 873 030	0,1769 %	376 M $
MFS International Singapore Pte. Ltd. 0,1715 %	3 755 587	0,1715 %	364 M $
Union Investment Privatfonds GmbH 0,1659 %	3 632 402	0,1659 %	352 M $

Nom	Actions	%	Valorisation
Dodge & Cox 0,6012 %	13 165 538	0,6012 %	1 274 M $
PRIMECAP Management Co. 0,5893 %	12 905 697	0,5893 %	1 248 M $
Eaton Vance Management 0,3239 %	7 092 253	0,3239 %	686 M $
Dimensional Fund Advisors LP 0,2776 %	6 078 175	0,2776 %	588 M $
Loomis, Sayles & Co. LP 0,2744 %	6 009 900	0,2744 %	581 M $
Fiduciary Trust Company International 0,2701 %	5 915 750	0,2701 %	572 M $
U.S. Trust Company of Delaware 0,2401 %	5 258 331	0,2401 %	509 M $
Wellington Management Co. LLP 0,2167 %	4 746 599	0,2167 %	459 M $
Wells Fargo Bank NA 0,1824 %	3 994 934	0,1824 %	386 M $
The Ayco Co. LP 0,1615 %	3 535 902	0,1615 %	342 M $

Nom	Actions	%	Valorisation
LUKB Expert Fondsleitung AG -	64 694	-	6 M $
ATP Fondsmaeglerselskab A/S -	46 082	-	4 M $
Swiss Rock Asset Management AG -	19 614	-	2 M $
Niederer & Partners AG -	5 300	-	513 818 $
JPMorgan Asset Management (China) Co Ltd. -	2 652	-	257 103 $
Liontrust Portfolio Management Ltd. -	474	-	45 953 $

Nom	Actions	%	Valorisation
NOVARTIS AG 6,63%	145 083 991	6,63%	14 073 485 173 $
SANDOZ GROUP AG 4,30%	18 524 209	4,30%	559 613 390 $
MORPHOSYS AG 11,57%	4 360 100	11,57%	316 438 618 $
NOVARTIS INDIA LIMITED 70,68%	17 450 680	70,68%	215 208 068 $
ERASCA, INC. 8,15%	12 307 692	8,15%	25 353 846 $
THIRD HARMONIC BIO, INC. 6,49%	2 642 762	6,49%	24 947 673 $
OCULIS HOLDING AG 4,68%	1 713 521	4,68%	20 647 928 $
POSEIDA THERAPEUTICS, INC. 6,12%	5 908 089	6,12%	18 846 804 $
MOLECULAR PARTNERS AG 4,78%	1 739 130	4,78%	7 095 929 $
PRECISION BIOSCIENCES, INC. 6,30%	413 577	6,30%	5 608 104 $

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com

Nom	Catégorie et Secteur
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis BioVenturesAG Novartis BioVenturesAG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The private company is based in Basel, Switzerland.	Investment Managers
NOVARTIS INDIA LIMITED	Pharmaceuticals: Major
Novartis Securities Investment Ltd. Novartis Securities Investment Ltd. Investment ManagersFinance Part of Novartis AG, Novartis Securities Investment Ltd. is an investment bank that offers investment advice. The private company is located in Bermuda.	Investment Managers
EBEWE Pharma Ges.m.b.H. Nfg.KG EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria.	Pharmaceuticals: Major
Novartis Capital Corp. Novartis Capital Corp. Finance/Rental/LeasingFinance Novartis Capital Corp. engages in the manufacture of pharmaceutical products. The company is headquartered in East Hanover, NJ.	Finance/Rental/Leasing
Novartis Finance SA	Finance/Rental/Leasing
Sandoz GmbH Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.	Pharmaceuticals: Major
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Holding AG Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The private company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment.	Financial Conglomerates
Novartis UK Pension Scheme	Investment Managers
Novartis Investments SARL Novartis Investments SARL Financial ConglomeratesFinance Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg.	Financial Conglomerates
Novartis Investment Ltd.
Novartis Healthcare Pvt Ltd. Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The private company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.	Pharmaceuticals: Major
Alcon Ophthalmika GmbH
Novartis Investment Ltd. (2120)
Novartis Services, Inc.
Sandoz Pvt Ltd. Sandoz Pvt Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz Pvt Ltd. is an Indian company that develops, manufactures and markets generic pharmaceutical products. The private company is based in Mumbai, India and was founded in 1995.	Pharmaceuticals: Generic
Novartis Pharma GmbH Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.	Pharmaceuticals: Major

Note Trading

Note Investissement

ESG Refinitiv

Plus de notations

Vente

Achat

Recommandation moyenne

ACCUMULER

Nombre d'Analystes

Dernier Cours de Cloture

97,84 USD

Objectif de cours Moyen

108,5 USD

Ecart / Objectif Moyen

+10,88 %

Consensus

Révisions des Estimations

Agenda de la société

	Varia. 1 janv.	Capi.
ELI LILLY AND COMPANY	+25,83 %	661 Md
NOVO NORDISK A/S	+27,00 %	566 Md
JOHNSON & JOHNSON	-6,76 %	352 Md
MERCK & CO., INC.	+20,34 %	332 Md
ABBVIE INC.	+3,00 %	283 Md
ASTRAZENECA PLC	+13,09 %	231 Md
ROCHE HOLDING AG	-9,61 %	195 Md
AMGEN INC.	-6,26 %	145 Md
PFIZER, INC.	-11,77 %	144 Md

Pharmacies - Autres

Recherche pharmaceutique et médicale

Produits pharmaceutiques

Produits pharmaceutiques

Pharmacies - Autres